"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."
"The mind-boggling profits that Gilead earned since the launch of sofosbuvir could treat every person currently waiting for the hepatitis C cure while earning over US$16 billion in profits for shareholders."
Syphilis is back and spreading quickly. What makes the resurgence of syphilis somewhat different this time is that the vast majority of these new cases are being found among men who have sex with men.
As STD prevention funding declines, the CDC is reporting a sharp increase in all STDs across the U.S. This fact sheet summarizes their findings.
Cases of congenital syphilis more than doubled in the U.S. since 2013, outpacing overall increases in STDs nationwide.
Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, according to preliminary data released today by the Centers for Disease Control and Prevention (CDC) at the National STD Prevention Conference...
Brand Name: Mavyret Other Names: Glecaprevir/Pibrentasvir, GLE/PIB Drug Class: Opportunistic Infections and Coinfections
What Is Mavyret?
Mavyret is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the ...
Brand Name: Vosevi Other Names: Sofosbuvir/Velpatasvir/Voxilaprevir, SOF/VEL/VOX Drug Class: Opportunistic Infections and Coinfections
What Is Vosevi?
Vosevi is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (F...